A patient story is only the beginning. The healthcare agency now called M+ builds the route from attention to action - and changes the route when the numbers tell it to.
A network of senior healthcare specialists turns complex medical stories into practical next steps. Behind M+ is a quieter experiment: giving experienced people a reason to stay.
A hospital cart, a contamination scanner and a cold-brew machine have something in common: Design Catapult. The California firm makes a business of the difficult distance between a clever idea and a product someone can actually use.
The Memphis nonprofit connects founders to buyers, investors and industry expertise. Its bet is that the next promising startup may begin with a problem a local company already needs solved.
The Houston nonprofit paired female founders with healthcare buyers and investors. Its announced 2026 wind-down reveals the cost of keeping those introductions useful.
A prototype can impress a room and still be impossible to manufacture. Cambridge Design Partnership has built a business in that awkward gap, fixing everything from diagnostic instruments to the feel of a kitchen knife.
Pumps, disposable circuits and patient records all meet in Spectrum Medical’s Quantum range. Its expansion shows the appeal of joining them together - and the scrutiny that comes with supplying life-support technology.
Its AI can release selected patients from an urgent cancer pathway without a dermatologist reviewing their images. The harder achievement is making that decision work inside a real health service.
The British implant maker is building a business around what an X-ray cannot tell you: how a replacement joint behaves in motion. Its wager joins metal, robotics and surgical data.

Across medical robotics, life science, pharmacy automation and patient-engagement software, Rick Green has kept returning to the same deceptively hard assignment: turn an intricate system into a story people can use.
A pharmacist saw life-science teams trying to prove product quality with paper, spreadsheets and disconnected software. Fourteen years and roughly $64 million in funding later, Qualio is betting that audit readiness can become a continuous operating system - with humans still holding the pen.

The XII Medical CEO has spent a career in the unglamorous middle of medical invention - where patents, payment, teams and patient access must eventually agree.

After helping take NeuroPace public, the engineer-turned-operator returned to a small clinical-stage company. His career makes a case for learning every room before taking the corner office.

After more than 25 years moving between large healthcare companies and lean startups, the Glycyx CEO has learned that biotech progress often depends on a less glamorous skill: turning a complicated premise into the next clear, fundable step.

After 16 years turning clinical problems into products, Kabir Gulati has taken the CEO seat at Carecubes. His new assignment is unusually tangible: help hospitals add isolation capacity without waiting for a building project.

Before an X-ray becomes an image, a detector has to catch what passes through. Liu Jianqiang made that overlooked layer the center of a 19-year engineering company.

Before she ran AliveCor, Priya Abani wrote validation tools for microprocessors and helped Alexa escape the Echo. Her career is a study in one portable skill: making complicated technology useful to ordinary people.

A programmer entered eye care with a prototype, listened when clinicians dismantled his assumptions, and stayed long enough to turn an unusual VR experiment into research infrastructure.

His route from Michigan engineering classrooms to a $130 million clinical-stage company is a study in useful detours, patient capital and the discipline to stop doing everything at once.

The Supira Medical CEO built his career by translating biomechanics into products, then learned to run a startup by staging risk, keeping options open and making clinical data do the talking.

Before Kaliber Labs put computer vision inside the operating room, its founder helped turn millions of tiny loans into a AAA-rated security. Ray Rahman’s career is a study in making scattered signals legible - then useful.

After a dozen years moving from product marketing to corporate strategy, Matthew Graybill arrived at GE HealthCare with a deceptively difficult brief: make a vast cardiovascular portfolio feel like one connected idea.

For nearly three decades at Boston Scientific, Mary Beth Moynihan has treated a career less like a ladder than a design problem: name the destination, map the missing experiences and make the next move count.

The Starling CEO has spent her career turning overlooked routines into design briefs. Her wager is simple: the most useful health technology may be the one people barely notice using.

She began by engineering ways to read rare cells in blood. At Cytovale, Anne Jensen has carried that same eye for signals from the research bench into the decisions that shape a growing diagnostics company.

Before Anthony Viscogliosi built medical-device companies, he built an information advantage. Four decades later, the analyst’s habit still shapes how he and his brothers buy, operate and sometimes buy back businesses.

The scientist who avoided business classes built Oova by treating entrepreneurship like research: assemble the right people, measure what matters, and let the evidence sharpen the idea.

A former Air Force pilot spent nearly two decades helping turn his father’s telescope insight into a new kind of ultrasound. The useful lesson is less about inspiration than patience: some ideas have to wait for computing power, regulators and the market to arrive.

She never planned to run a business. Then a Duke project refused to remain a project, and Denali Dahl learned to translate laboratory precision into the stubborn work of building Kalia Health.

A first-generation device, dozens of prototypes and a pandemic could have ended Transverse Medical. Eric Goslau turned each interruption into another design brief - and made resilience part of the product.